Advanced imaging uncovers that glioblastoma affects the skull and immune system, not just the brain.
Key Details
- 1Montefiore Einstein researchers found glioblastoma erodes skull bones and alters skull marrow immune makeup.
- 2CT imaging of patients showed similar skull erosions as seen in mouse models with glioblastoma.
- 3Single-cell RNA sequencing revealed a shift toward pro-inflammatory immune cells in the skull marrow.
- 4FDA-approved osteoporosis drugs halted skull erosion but made tumors more aggressive and impaired immunotherapy effects.
- 5Findings suggest glioblastoma should be seen as a systemic, not just local, disease.
Why It Matters
These findings highlight the need for radiologists to consider extracranial effects when imaging glioblastoma and suggest that traditional local-treatment approaches may overlook critical systemic interactions. Understanding these effects can influence both diagnostic imaging strategies and future treatment planning.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.